Matthew Roden, Founder of Aktis Oncology

Matthew Roden is the founder of Aktis Oncology. Aktis Oncology has raised $175M, latest Series B $175M. Biotech · Boston, MA.

About Matthew Roden

Matthew Roden is the founder of Aktis Oncology. Aktis Oncology operates in Biotech and is based in Boston, MA. Aktis Oncology has raised $175M, latest Series B $175M. Backers on record include Todd Davis, Janus Henderson Investors.

Matthew Roden at a glance

Company
Aktis Oncology
Industry
Biotech
Location
Boston, MA
Total raised
$175M
Investors on record
Todd Davis, Janus Henderson Investors

Frequently asked about Matthew Roden

Who is Matthew Roden?
Matthew Roden is the founder of Aktis Oncology. Full profile, funding history and background on StartupFundraising.com.
What company did Matthew Roden found?
Matthew Roden founded Aktis Oncology, a Biotech company based in Boston, MA.
How do I contact Matthew Roden?
Verified contact routes including LinkedIn, background and funding history for Matthew Roden are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Boston — who backed them, at what stage, and how much they raised.

Aktis Oncology funding profile (1)

More Biotech founders (40)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library